Clinicopathological Features and Survival Rate of Colorectal Adenocarcinoma Patients with and without a KRAS Mutation: a FiveYear Study in Yazd, Iran.

@article{Zahir2016ClinicopathologicalFA,
  title={Clinicopathological Features and Survival Rate of Colorectal Adenocarcinoma Patients with and without a KRAS Mutation: a FiveYear Study in Yazd, Iran.},
  author={Shokouh Taghipour Zahir and Mohammadreza NazemianYazdi and Peyman Arasteh and Mohammadreza Mortazavizadeh and Mohammad Karbalaeian and Malihe ZareMehrjardi},
  journal={Asian Pacific journal of cancer prevention : APJCP},
  year={2016},
  volume={17 7},
  pages={3417-22}
}
BACKGROUND By some estimates, colorectal carcinoma is the third most common cancer worldwide. The most appropriate method of treatment, especially of its metastatic form, is determined based on KRAS status. The present study was conducted on patients with colorectal cancer positive or neagtive for a KRAS mutation in terms of survival rate and the response… CONTINUE READING